FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Tko Group Holdings Reports Q1 2026 Earnings Beat; Revenue In Line

作者

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

TKO reported mixed Q1 2026 results with EPS of $1.12 beating consensus by $0.06, while revenue of $1.6B (+26%) was only in line with estimates. Growth was fueled by IMG integration and broad-based strength across UFC, WWE, and IMG segments. Despite mixed top-line performance, profitability metrics showed improvement with Adjusted EBITDA advancing 32% to $549.8M and margin expanding 100 bps to 34%. Management reaffirmed full-year 2026 guidance of $5.68B-$5.78B in revenue and $2.24B-$2.29B in Adjusted EBITDA. The company delivered exceptional cash generation with free cash flow of $674.5M and returned $1.0B to shareholders through buybacks and dividends. We believe the diversified revenue model provides strong visibility, with new media rights deals including the $1.1B annual Paramount agreement and ESPN/Netflix contracts supporting future growth. In our view, the additional $1B buyback authorization signals board confidence in the business model and cash flow trajectory as we look ahead in 2026-2027.

相關文章

Asia

台灣森寶製藥第一季獲利1,650萬新台幣

根據週三提交給台灣交易所的文件,台灣森寶製藥(TPE:1789)公佈今年第一季歸屬於股東的利潤為新台幣1,650萬元,即每股0.02元。 週四午盤交易中,該公司股價下跌超過2%。 該公司表示,第一季營業收入為新台幣6.597億元。 該公司未提供去年同期數據。

$TPE:1789
Asia

Kina Securities 發行巴布亞紐幾內亞首筆批發公司債券

根據週四提交給澳洲證券交易所的文件顯示,基納證券(ASX:KSL)發行的2.35億巴布亞紐幾內亞亞基納、10年期無擔保次級批發公司債券已於週三在巴布亞新幾內亞國家證券交易所運營商PNGX Markets上市。 這是巴布亞紐幾內亞首隻上市的批發公司債。 該公司預計此次發行將有助於增強其資產負債表實力,實現資本管理目標,並促進其銀行和金融服務業務的成長。 該公司股價在周四的交易中上漲了1%。

$ASX:KSL
Asia

首頁 > 第一季獲利飆升至15億印度盧比,超乎預期

印度Home First Finance Company(NSE:HOMEFIRST,BOM:543259)截至3月31日的第四財季稅後利潤增至14.9億印度盧比,高於去年同期的10.5億盧比。 這家金融服務提供商週三向印度證券交易所提交的文件顯示,每股收益為14.22盧比,高於去年同期的11.45盧比。這項每股收益高於Visible Alpha調查的分析師預期的14.08盧比。 營業總收入也從去年同期的21.5億盧比增加到50.1億盧比。 公司董事會建議派發截至3月31日止財政年度的股息,每股面額為2盧比的股票股利5.20盧比。 該公司股價在最近的交易中下跌了2%。

$BOM:543259$NSE:HOMEFIRST